Printer Friendly

Zacks.com Announces That Ron Rowland Highlights the Following Funds: Fidelity Select Medical Delivery and Fidelity Capital Appreciation.

Business Editors

CHICAGO--(BUSINESS WIRE)--Nov. 24, 2003

Ron Rowland says that recent pullbacks are part of a correction, and not the beginning of a decline. So there's still plenty of opportunity for investors to use mutual funds to gain higher returns, and this expert has a new recommendation for you. Learn about Fidelity Capital Appreciation (OTC:FDCAX) and Fidelity Select Medical Delivery (OTC:FSHCX). Click here for the full story exclusively on Zacks.com: http://featuredexpert2bw.zacks.com/

Here are the highlights from the Featured Expert column:

After a bumpy start Thursday morning, the markets managed to move into positive territory for a brief period, but they simply could not keep up the pace. The market's wishy-washy performance on Thursday had to do with Friday's triple witching options expiration. It used to be that expiration Friday was a day on which the market would experience increased volatility. These days, that heightened uncertainty seems to affect the market a day or two earlier.

Ron Rowland has commented before on the market's lack of ability to follow through to the upside when reacting to good economic news. But the longer-term technical signs are not looking ominous as yet. The market remains in an overall up-trend, and the current pullback is probably just a correction, not the beginning of a decline.

Rowland is recommending the exchange of Fidelity Capital Appreciation (OTC:FDCAX) into Fidelity Select Medical Delivery (OTC:FSHCX). Medical Delivery has been on the rise lately, having begun an up-trend in April of this year. It is currently ranked number two in Rowland's Select fund rankings.

Read all of Ron Rowland's commentary, and don't miss his complete fund rankings by clicking: http://featuredexpert3bw.zacks.com/

About Zacks Featured Experts

To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Recommendations from Featured Experts Highlighted in FREE Investment Newsletter

The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: http://www.freeprofit1bw.zacks.com

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://www.freeprofitbw.zacks.com

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 24, 2003
Words:591
Previous Article:Zacks.com Announces That Mike Chrisman Highlights the Following Stocks: Sohu.com, Sina Corp., McDonald's, Altria, United Technologies, and...
Next Article:UPU Industries Begins Construction of Its First North American Plant in Kansas, an Advisory from Industrialinfo.com.


Related Articles
On the mend.
Betting on biotechnology: biotech funds may have a bright future ahead in spite of a down 2001. (Mutual Fund Focus).
CHOOSING MUTUAL FUNDS; READY TO INVEST? HERE'S HOW TO GET STARTED.
FIDELITY SHUFFLES PLAN MANAGERS\Goal is for investment portfolios to reflect funds' stated purpose.
Ron Rowland Highlights: Fidelity Select Pharma, Rydex Biotech, Fidelity Select Health Care, Fidelity Select Medical Equipment & Systems, and Fidelity...
Zacks.com Announces that Ron Rowland Highlights the Following Funds: Fidelity Select Medical Delivery and Fidelity Select Developing Communications.
Long-distance funds: despite the market, these 100 champs will finish strong when other contenders run out of gas.
Diversify & conquer: experienced management and varied investment vehicles are key to beating lackluster returns. Here are 100 funds that hit the...
Time for tech? As YouTube continues to generate buzz and Google trades at near $500 per share, the tech sector may be ready to regain market...

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters